The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Recruiting

Encorafenib & BinimetinibThe FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials

Sponsor:

Pfizer

Code:

NCT05203172

Conditions

Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Binimetinib only treatment

Encorafenib only Treatment

Encorafenib & Binimetinib Treatment

Treatment of Encorafenib & Binimetinib & Ribociclib

Treatment of Encorafenib & Binimetinib & Cetuximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-09. This information was provided to ClinicalTrials.gov by Pfizer on 2025-08-14.